Stockreport

Praxis Precision Medicines to Present at Upcoming December Investor Conferences

Praxis Precision Medicines, Inc.  (PRAX) 
PDF BOSTON, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into [Read more]